Intracranial meningiomas;Meningeoma intracraniale: Ny viden

Ugeskrift for Laeger

Volumn 163, Issue 19, 2001, Pages 2618-2622

  Andersen, Claus ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR;

BRAIN TUMOR; CHROMOSOME 22; CHROMOSOME DELETION; CLASSIFICATION; DRUG EFFECT; HUMAN; MENINGIOMA; METABOLISM; MULTIMODALITY CANCER THERAPY; REVIEW; RISK FACTOR;

BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; COMBINED MODALITY THERAPY; HUMANS; MENINGIOMA; RECEPTORS, CELL SURFACE; RISK FACTORS;

EID: 0035821517     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Christensen J, Klarskov H, Raffn E, Gjerris F, Olsen JH. Primære intrakraniale og intraspinale neoplasmer i Danmark 1943-1987. Ugeskr Læger 1995; 157: 5716-20.
2. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RO, Martuza RL. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985; 62: 18-24.
3. Al-Mefty O. Meningiomas. New York: Raven Press, 1991.
4. Kleihues P, Burger PC, Scheithauer BW, World Health Organisation. International histological classification of tumours. Berlin, Heidelberg, New York: Springer Verlag, 1993.
5. Adegbite AB, Khan MI, Paine KWE, Tan LK. The recurrence of intracranial meningeomas after surgical treatment. J Neurosurg 1983; 58: 51-6.
6. Jääskeläinen J. Seemingly complete removal af histologically benign intracranial meningeoma: late recrrence rate and factors prediction recurrence in 657 patients. A multivariate analysis. Surg Neurol 1986; 26: 461-9.
7. Maier H, Ofner D, Hittmair A, Kitz K, Budka H. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 1992; 77: 616-23.
8. Shibuya M, Hoshino T, Ito S, Wacker MR, Prados M, Davis RL et al. Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labelling. Neurosurgery 1992; 30: 494-8.
9. Mathiesen T, von Holst H, Askensten U, Collins PV. DNA-determination in the clinical management of patients with meningioma or haemangioblastoma. Br J Neurosurg 1989; 3: 575-82.
10. Modan B, Baidatz D, Mart H, et al. Radiation-induced head and neck tumours. Lancet 1974; 1: 277-9.
11. Cushing H, Eisenhardt L. Meningiomas: Their classification, regional behaviour, life history and surgical end results. Spingfield, IL.: Charles C. Thomas, 1938.
12. Annegers JF, Laws ER, Kurland LT, Grabow JD. Head trauma and subsequent brain tumors. Neurosurgery 1979; 4: 203-6.
13. Donnel MS, Meyer GA, Donegan WL. Estrogen-receptor protein in intracranial meningiomas. J Neurosurg 1979; 50: 499-502.
14. Poisson M, Pertuiset BF, Hauw JJ, Philippon J, Buge A, Moguilewsky M et al. Steroid hormones in human meningeomas, gliomas and brain metastases. J Neurooncol 1983; 1: 179-89.
15. Schrell UMH, Adams EF, Fahlbusch R. Hormonal dependency of crebral meningiomas. Part I: female sex steroid receptors and their significance as specific markes for adjuvant medical therapy. J Neurosurg 1990; 73: 743-9.
16. Brandis A, Mirzai S, Tatagiba M, Walter GF, Samii M, Ostertag H. Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and historical features. Neurosurgery 1993; 33: 212-8.
17. Cass SP, Hirsch BE, Stechison MT. Evolution and advances of the lateral surgical approaches to cranial base neoplasms. J Neurooncol 1994; 20: 337-61.
18. Grunberg SM, Weiss MH, Spitz IM, Ahmadi J, Sadun A, Russell CA et al. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 1991; 74: 861-6.
19. Lamberts SW, Tanghe HL, Avezaat CJ, Braakman R, Wijngaarde R, Koper JW et al. Mifepristone (RU 486) treatment of meningiomas. J Neurol Neurosurg Psychiatry 1992; 55: 486-90.
20. Becker PB, Gloss B, Schmid W, et al. In vivo protein DNA interactions in a glucocorticoid response element require the presence of the hormone. Nature 1986; 324: 686-9.
21. Klutmann S, Bohuslavizki KH, Brenner W, Behnke A, Tietje N, Kroger S et al. Somatostatin receptor scintigraphy in postsurgical follow-up examinations of meningioma. J Nucl Med 1998; 39: 1913-7.
22. Koper JW, Markstein R, Kohler C, Kwekkeboom DJ, Avezaat CJ, Lamberts SW et al. Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth. J Clin Endocrinol Metab 1992; 74: 543-7.
23. Schrell UMH, Nomikos P, Fahlbusch R. Presence of dopamine D1 receptors and absence of D2 receptors in human cerebral meningioma tissue. J Neurosurg 1992; 77: 288-94.
24. Inamura T, Nishio S, Takeshita I, Fujiwara S, Fukui M. Peritumoral brain edema in meningiomas. Influence of vascular supply on its development. Neurosurgery 1992; 31: 179-85.
25. Philippon J, Foncin JF, Grob R, Srour A, Poisson M, Pertuiset BF. Cerebral edema associated with meningeomas: possible role of a secretory-excretory phenomenon. Neurosurgery 1984; 14: 295-301.
26. Go KG, Wilmink JT, Molenaar WM. Peritumoral brain edema associated with meningeomas. Neurosurgery 1988; 23: 175-9.
27. Demaerel P, Johannik K, van Hecke P, van Ongeval C, Vereller S, Marchai G. Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comp Assist Tomogr 1991; 15: 67-76.
28. Andersen C, Astrup J, Gyldensted C. Quantitative MR analysis of glucocorticoid effects on peritumoral edema associated with intracranial meningiomas and metastases. J Comp Assist Tomogr 1994; 18: 509-18.
29. Andersen C, Haselgrove JC, Doenstrup S, Astrup J, Gyldensted C. Resorption of peritumoral edema in cerebral gliomas during dexamethasone treatment evaluated by NMR relaxation time imaging. Acta Neurochir (Wien) 1993; 122: 218-24.
30. Simpson D. Recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psych 1957; 20: 22-39.
31. Papo I. Intracranial meningiomas in the elderly in the CT scan era. Acta Neurochir (Wien) 1983; 67: 195-204.
32. Nakasu S, Hirano A, Shimura T, Llena JE. Incidental meningiomas in autopsy study. Surg Neurol 1987; 27: 319-22.
33. Olivero WC, Lister JR, Elwood PW. The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg 1995; 83: 222-4.
34. Firsching RP, Fischer A, Peters R, Thun F, Klug N. Growth rate of incidental meningiomas. J Neurosurg 1990; 73: 545-7.
35. Salpietro FM, Alafaci C, Lucerna S, Iacopino DG, Todaro C, Tomasello F. Peritumoral edema in meningiomas: microsurgical observations of different brain tumor interfaces related to computed tomography. Neurosurgery 1994; 35: 638-42.
36. Awad IA, Kalfas I, Hahn JF, Little JR. Intracranial meningiomas in the aged: surgical outsome in the era of computerized tomography. Neurosurgery 1989; 24: 557-60.
37. Hoffman WF, Mühleisen H, Hess CF, Kortmann RD, Schmidt B, Grote EH et al. Atypical and anaplastic meningiomas. Does the new WHO-classification of brain tumors affect the indication for postoperative irradiation? Acta Neurochir (Wien) 1995; 135: 171-8.
38. Kondziolka D, Lunsford LD, Coffey RJ, Flickinger JC. Stereotactic radiosurgery of meningiomas. J Neurosurg 1991; 74: 552-9.